Evogene Ltd. (EVGN)
0.3822
-0.02
(-4.09%)
USD |
NASDAQ |
Oct 09, 16:00
0.3907
+0.01
(+2.22%)
Pre-Market: 20:00
Evogene Net Income (Quarterly) : -1.591M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.591M |
| March 31, 2026 | -5.91M |
| December 31, 2025 | -5.338M |
| September 30, 2025 | -2.729M |
| June 30, 2025 | -3.01M |
| March 31, 2025 | -1.903M |
| December 31, 2024 | 0.983M |
| September 30, 2024 | -6.748M |
| June 30, 2024 | -4.553M |
| March 31, 2024 | -3.845M |
| December 31, 2023 | -7.337M |
| September 30, 2023 | -3.858M |
| June 30, 2023 | -7.778M |
| March 31, 2023 | -6.981M |
| December 31, 2022 | -3.821M |
| September 30, 2022 | -7.163M |
| June 30, 2022 | -9.754M |
| March 31, 2022 | -9.106M |
| December 31, 2021 | -8.084M |
| September 30, 2021 | -8.343M |
| June 30, 2021 | -6.898M |
| March 31, 2021 | -7.12M |
| December 31, 2020 | -8.763M |
| September 30, 2020 | -5.411M |
| June 30, 2020 | -4.818M |
| Date | Value |
|---|---|
| March 31, 2020 | -7.214M |
| December 31, 2019 | -6.692M |
| September 30, 2019 | -4.528M |
| June 30, 2019 | -4.141M |
| March 31, 2019 | -3.754M |
| December 31, 2018 | -5.829M |
| September 30, 2018 | -4.828M |
| June 30, 2018 | -4.769M |
| March 31, 2018 | -5.386M |
| December 31, 2017 | -6.224M |
| September 30, 2017 | -5.024M |
| June 30, 2017 | -4.743M |
| March 31, 2017 | -4.847M |
| December 31, 2016 | -6.643M |
| September 30, 2016 | -5.114M |
| June 30, 2016 | -4.463M |
| March 31, 2016 | -3.372M |
| December 31, 2015 | -5.472M |
| September 30, 2015 | -3.382M |
| June 30, 2015 | -4.95M |
| March 31, 2015 | -3.409M |
| December 31, 2014 | -4.823M |
| September 30, 2014 | -4.179M |
| June 30, 2014 | -3.191M |
| March 31, 2014 | -2.337M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Compugen Ltd. | -7.006M |
| Pluri, Inc. | -6.193M |
| Scinai Immunotherapeutics Ltd. | -2.037M |
| CollPlant Biotechnologies Ltd. | -2.726M |
| Regentis Biomaterials Ltd. | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.347M |
| Total Expenses (Quarterly) | 1.939M |
| EPS Diluted (Quarterly) | -0.1449 |
| Enterprise Value | 6.981M |
| Gross Profit Margin (Quarterly) | -2.31% |
| Profit Margin (Quarterly) | -458.5% |
| Earnings Yield | -238.7% |
| Normalized Earnings Yield | -238.67 |